Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma

NCT00735345 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped because of safety concerns the study was terminated prematurely

Conditions

Esophageal Cancer

Interventions

DRUG: 5-FU
DRUG: Cisplatin
DRUG: Taxotere
BIOLOGICAL: Cetuximab
RADIATION: Radiation during chemoradio-immunotherapy

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Collaborators

[object Object]
[object Object]